Visugromab in Cachexia International Trial is a research study to test a new drug, **visugromab**, for people with certain cancers, like lung and bowel cancer, who also experience **cachexia**. Cachexia means losing weight without trying, which often happens in cancer patients. The study wants to find out if visugromab can help patients gain weight, improve appetite, and move better.
Participants will receive either visugromab or a placebo (a harmless substance that looks like the drug) through a drip into their vein. They will visit the hospital or clinic every 4 weeks for treatment, checkups, and tests. The study will also check for any side effects from the drug.
Key Points:
- Participants visit the hospital once every 4 weeks.
- Visugromab is compared to a placebo.
- Participants must not join other trials or use other investigational treatments within 4 weeks before starting this study.
How understandable was the trial content above?
Hard to understand
Easy to understand